DE2629200A1 - Oral verabfolgbares festes antidepressionsmittel und dessen herstellung - Google Patents

Oral verabfolgbares festes antidepressionsmittel und dessen herstellung

Info

Publication number
DE2629200A1
DE2629200A1 DE19762629200 DE2629200A DE2629200A1 DE 2629200 A1 DE2629200 A1 DE 2629200A1 DE 19762629200 DE19762629200 DE 19762629200 DE 2629200 A DE2629200 A DE 2629200A DE 2629200 A1 DE2629200 A1 DE 2629200A1
Authority
DE
Germany
Prior art keywords
ascorbic acid
agent
amount
lofepramine
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19762629200
Other languages
German (de)
English (en)
Other versions
DE2629200C2 (enExample
Inventor
Edgar Eriksoo
Korfitz Bengt Ingvar Ohlsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AB
Original Assignee
Leo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo AB filed Critical Leo AB
Publication of DE2629200A1 publication Critical patent/DE2629200A1/de
Application granted granted Critical
Publication of DE2629200C2 publication Critical patent/DE2629200C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19762629200 1975-07-03 1976-06-29 Oral verabfolgbares festes antidepressionsmittel und dessen herstellung Granted DE2629200A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB28136/75A GB1498857A (en) 1975-07-03 1975-07-03 Antidepressant composition

Publications (2)

Publication Number Publication Date
DE2629200A1 true DE2629200A1 (de) 1977-02-03
DE2629200C2 DE2629200C2 (enExample) 1987-06-11

Family

ID=10270823

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762629200 Granted DE2629200A1 (de) 1975-07-03 1976-06-29 Oral verabfolgbares festes antidepressionsmittel und dessen herstellung

Country Status (8)

Country Link
US (1) US4061747A (enExample)
JP (1) JPS6045162B2 (enExample)
BE (1) BE843690A (enExample)
CA (1) CA1059912A (enExample)
DE (1) DE2629200A1 (enExample)
FR (1) FR2315936A1 (enExample)
GB (1) GB1498857A (enExample)
IE (1) IE43165L (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4108119A1 (de) * 1991-03-13 1992-09-17 Jellalabad Ltd Verfahren zur herstellung von 4'-chlor-2-((3-(10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl) methylaminno) acetophenon und seiner salze, die stabilisierungseiner salze, hierbei erhaeltliche produkte und pharmmazeutische zubereitungen, die diese enthalten

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0045238B1 (en) * 1980-07-29 1986-10-01 Sanofi S.A. Acid stabilized compositions of thieno-pyridine derived compounds and process for preventing degradation of such compounds
US5312819A (en) * 1990-08-20 1994-05-17 Sandoz Ltd. Pharmaceutical compositions comprising clozapine and a radical scavenger
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1177525A (en) 1967-04-13 1970-01-14 Leo Ab New Heterocyclic Aminoketones of Therapeutic Interest

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Fiedler, H.P.: Lexikon der Hilfsstoffe für Pharmazie, Kosmetik und angrenzende Gebiete, 1971, S. 68 *
Voigt, R.: Lehrbuch der pharmazeutischen Technologie, 1973, S. 559 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4108119A1 (de) * 1991-03-13 1992-09-17 Jellalabad Ltd Verfahren zur herstellung von 4'-chlor-2-((3-(10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl) methylaminno) acetophenon und seiner salze, die stabilisierungseiner salze, hierbei erhaeltliche produkte und pharmmazeutische zubereitungen, die diese enthalten

Also Published As

Publication number Publication date
JPS527420A (en) 1977-01-20
FR2315936B1 (enExample) 1979-03-30
BE843690A (fr) 1977-01-03
IE43165B1 (en) 1980-12-31
JPS6045162B2 (ja) 1985-10-08
DE2629200C2 (enExample) 1987-06-11
GB1498857A (en) 1978-01-25
FR2315936A1 (fr) 1977-01-28
IE43165L (en) 1987-01-03
US4061747A (en) 1977-12-06
CA1059912A (en) 1979-08-07

Similar Documents

Publication Publication Date Title
DE3685927T2 (de) Vitamine enthaltende granule.
EP0047899B2 (de) Feste Arzneizubereitungen enthaltend Nifedipin und Verfahren zu ihrer Herstellung
EP2477660B1 (de) Pharmazeutische zusammensetzung mit den wirkstoffen metformin und sitagliptin oder vildagliptin
DE2224534B2 (de) Pharmazeutisches praeparat mit langsamer wirkstoffabgabe
DE60036014T2 (de) Methode zur stabilisierung von benzimidazol-verbindungen
DE2813146A1 (de) Tablettieren von mikrokapseln
DE2725390A1 (de) Dragee und verfahren zu seiner herstellung
DE2545973A1 (de) Digoxinarzneimittel in form von einzelnen kapseln und verfahren zu seiner herstellung
DE2246037B2 (de) Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
EP0625355B2 (de) Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
DE60319707T2 (de) Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose
DE3586185T2 (de) Verfahren zur herstellung von etofibrat oder aehnliche verbindungen enthaltende mikrogranula mit verzoegerter freisetzung sowie die auf diese weise erhaltenen produkte.
DE69108007T2 (de) Verfahren zur herstellung einer einen wärme-, licht- und feuchtigkeit empfindlichen wirkstoff mit einer monoklinisch kristallinen struktur enthaltenden tabletten oder dragee zusammensetzung.
DE19740983A1 (de) Verfahren zur Erschwerung der Extraktion von Wirkstoffen aus Tabletten
DE69907495T2 (de) (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on als reine verbindung
DE60131863T2 (de) Stabilisierung von festen schilddrüsenhormonzusammensetzungen
DD218349A5 (de) Verfahren zur herstellung von 2-tert.-butylamino-3-chlorpropiophenonmaleat
DE2629200C2 (enExample)
DE69209916T2 (de) Oral anzuwendende Arzneimittel Dapiprazol enthaltend
DE60220953T2 (de) Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon
DE69103724T2 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren.
DE3419129A1 (de) Nifedipinpraeparate und verfahren zu ihrer herstellung
DE69005993T2 (de) Verfahren zur Herstellung eines Ranitidin-Harz-Absorbates.
DE3325652C2 (enExample)
EP1631252B1 (de) Verfahren zur herstellung einer festen pharmazeutischen zusammensetzung

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: BERENDT, T., DIPL.-CHEM. DR., PAT.-ANW., 8000 MUEN

8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: H. LUNDBECK AB, HELSINGBORG, SE

8328 Change in the person/name/address of the agent

Free format text: BERENDT, T., DIPL.-CHEM. DR. LEYH, H., DIPL.-ING. DR.-ING. HERING, H., DIPL.-ING., PAT.-ANWAELTE, 81667 MUENCHEN